Adoptive T Cell Immunotherapy for Cancer

@inproceedings{Perica2015AdoptiveTC,
  title={Adoptive T Cell Immunotherapy for Cancer},
  author={Karlo Perica and Juan Carlos Varela and Mathias Oelke and Jonathan P Schneck},
  booktitle={Rambam Maimonides medical journal},
  year={2015}
}
Harnessing the immune system to recognize and destroy tumor cells has been the central goal of anti-cancer immunotherapy. In recent years, there has been an increased interest in optimizing this technology in order to make it a clinically feasible treatment. One of the main treatment modalities within cancer immunotherapy has been adoptive T cell therapy (ACT). Using this approach, tumor-specific cytotoxic T cells are infused into cancer patients with the goal of recognizing, targeting, and… CONTINUE READING

Figures and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 51 CITATIONS

Challenges of Adoptive (T-)cell Transfer Immunotherapy for Cancer

VIEW 10 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Engineered T Cell Therapy for Cancer in the Clinic

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Application Of Adoptive Immunotherapy In Ovarian Cancer

VIEW 1 EXCERPT
CITES BACKGROUND

DLL3: an emerging target in small cell lung cancer

FILTER CITATIONS BY YEAR

2015
2020

CITATION STATISTICS

  • 3 Highly Influenced Citations

  • Averaged 14 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 54 REFERENCES

Cytotoxic Tlymphocyte immunotherapy for ovarian cancer: a pilot study

  • CA Phillips, M Townsend, +3 authors W. Robinson
  • J Immunother
  • 2012